Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-alcoholic fatty liver disease in a sample of individuals with bipolar disorders: results from the FACE-BD cohort.
Godin O, Leboyer M, Belzeaux R, Bellivier F, Loftus J, Courtet P, Dubertret C, Gard S, Henry C, Llorca PM, Schwan R, Passerieux C, Polosan M, Samalin L, Olié E, Etain B; FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators. Godin O, et al. Acta Psychiatr Scand. 2021 Jan;143(1):82-91. doi: 10.1111/acps.13239. Epub 2020 Nov 24. Acta Psychiatr Scand. 2021. PMID: 33011976
Childhood maltreatment and metabolic syndrome in bipolar disorders: In search of moderators.
Godin O, Gaube G, Olié E, Belzeaux R, Bellivier F, Loftus J, Courtet P, Dubertret C, Llorca PM, Gard S, Henry C, Schwan R, Passerieux C, Polosan M, Samalin L, Leboyer M, Etain B; FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators. Godin O, et al. Psychoneuroendocrinology. 2021 Sep;131:105327. doi: 10.1016/j.psyneuen.2021.105327. Epub 2021 Jun 15. Psychoneuroendocrinology. 2021. PMID: 34182249 Free article.
Global and local cortical folding alterations are associated with neurodevelopmental subtype in bipolar disorders: a sulcal pits analysis.
Lefrere A, Auzias G, Favre P, Kaltenmark I, Houenou J, Piguet C, Polosan M, Eyler LT, Phillips ML, Versace A, Wessa M, McDonald C, Cannon DM, Brambilla P, Bellani M, Deruelle C, Belzeaux R. Lefrere A, et al. J Affect Disord. 2023 Mar 15;325:224-230. doi: 10.1016/j.jad.2022.12.156. Epub 2023 Jan 4. J Affect Disord. 2023. PMID: 36608853
Definition of early age at onset in bipolar disorder according to distinctive neurodevelopmental pathways: insights from the FACE-BD study.
Corponi F, Lefrere A, Leboyer M, Bellivier F, Godin O, Loftus J, Courtet P, Dubertret C, Haffen E, Llorca PM, Roux P, Polosan M, Schwan R, Samalin L, Olié E, Etain B; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorder) Groups; Seriès P, Belzeaux R. Corponi F, et al. Among authors: lefrere a. Psychol Med. 2023 Feb 28:1-9. doi: 10.1017/S003329172300020X. Online ahead of print. Psychol Med. 2023. PMID: 36852971
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P. Vidal N, et al. Among authors: lefrere a. Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21. Eur Neuropsychopharmacol. 2023. PMID: 37741163 Review.
Subjects suffering from bipolar disorder taking lithium are less likely to report physical pain: a FACE-BD study.
Risch N, Dubois J, Etain B, Aouizerate B, Bellivier F, Belzeaux R, Dubertret C, Haffen E, Januel D, Leboyer M, Lefrere A, Samalin L, Polosan M, Rey R, Roux P, Schwan R, Walter M; FondaMental Advanced Centres of Expertise in Bipolar Disorders (FACE-BD) Collaborators; Courtet P, Olié E. Risch N, et al. Among authors: lefrere a. Eur Psychiatry. 2023 Dec 13;67(1):e8. doi: 10.1192/j.eurpsy.2023.2476. Eur Psychiatry. 2023. PMID: 38086540 Free PMC article.
Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE-BD cohort.
Godin O, Olié E, Fond G, Aouizerate B, Aubin V, Bellivier F, Belzeaux R, Courtet P, Dubertret C, Haffen E, Lefrere A, Llorca PM, Polosan M, Roux P, Samalin L, Schwan R; FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators; Leboyer M, Etain B. Godin O, et al. Among authors: lefrere a. Acta Psychiatr Scand. 2024 Mar;149(3):207-218. doi: 10.1111/acps.13655. Epub 2024 Jan 24. Acta Psychiatr Scand. 2024. PMID: 38268142
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1.
Spano L, Marie-Claire C, Godin O, Lebras A, Courtin C, Laplanche JL, Leboyer M, Aouizerate B, Lefrere A, Belzeaux R, Courtet P, Olié E, Dubertret C, Schwan R, Aubin V, Roux P, Polosan M, Samalin L, Haffen E; Fondamental Advanced Centers Of Expertise In Bipolar Disorders (Face-Bd) Collaborators; Bellivier F, Etain B. Spano L, et al. Among authors: lefrere a. Transl Psychiatry. 2024 Mar 1;14(1):131. doi: 10.1038/s41398-024-02824-z. Transl Psychiatry. 2024. PMID: 38429270 Free PMC article.
Factors associated with lamotrigine concentration/dose ratio in individuals with bipolar disorders.
Chouchana M, Delage C, Godin O, Fontan JE, Bellivier F, Gard S, Aubin V, Belzeaux R, Dubertret C, Haffen E, Leboyer M, Olie E, Courtet P, Polosan M, Roux P, Samalin L, Schwan R, Lefrere A, Bloch V, Etain B; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD). Chouchana M, et al. Among authors: lefrere a. Eur Neuropsychopharmacol. 2023 Aug;73:75-81. doi: 10.1016/j.euroneuro.2023.04.005. Epub 2023 May 4. Eur Neuropsychopharmacol. 2023. PMID: 38465581
12 results